BioSpace News Archive

All three companies have invested millions in the facilities to expand their global footprint.

The U.S. Department of Justice has leveled more charges against members of the U.S. science community who have alleged ties to China.

They dub it a type of Trojan Horse and believe it has the potential to treat atherosclerosis, a top cause of death in the U.S.

It has been said that qualifications are more of a “wish list” for employers, who do not expect to find someone who meets all the requirements.

In line with the firm’s corporate mission of delivering a “Beautiful and Better Life”, Proya Cosmetics Co., Ltd. (SHA: 603605) is contributing to the effort to control and prevent further expansion of the 2019 novel Coronavirus (2019-nCoV) epidemic during these critical days.

Spring Bank Pharmaceuticals, Inc. (Nasdaq: SBPH), a clinical-stage biopharmaceutical company developing novel therapeutics for the treatment of viral infections, inflammatory diseases and certain cancers, today announced that it has discontinued development of inarigivir soproxil, which was in Phase 2 development for the treatment of chronic hepatitis B virus (HBV).

Tivity Health, Inc. (Nasdaq: TVTY) today announced that its financial results for the fourth quarter and full year ending December 31, 2019, will be released after market close on Wednesday, February 19, 2020, followed the same day by a conference call and live webcast scheduled for 5:00 p.m. ET.

Current Health will offer its RPM device to C-section patients at Ugandan hospital to improve inpatient monitoring

Algae Health Sciences, a division of BGG, announced the peer-reviewed publication of a review paper which evaluates head-to-head studies comparing Astaxanthin from three different sources in animals and in-vitro

A Purdue University–affiliated company using artificial intelligence to improve health care delivery has received a $500,000 investment from Purdue Research Foundation’s Foundry Investment Fund to help them advance medical technology.